货号:A378777
同义名:
曲洛斯坦
/ Win 24540; Desopan
Trilostane is an inhibitor of 3 β-hydroxysteroid dehydrogenase for Cushing's syndrome.


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Dehydrogenase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trilostane | ✔ | 99+% | |||||||||||||||||
| AGI-6780 |
+++
IDH2 R140Q mutant, IC50: 23 nM |
99%+ | |||||||||||||||||
| Gimeracil | ✔ | 98% | |||||||||||||||||
| AGI-5198 |
++
R132C-IDH1, IC50: 0.16 μM R132H-IDH1, IC50: 70 nM |
99%+ | |||||||||||||||||
| SW033291 |
++++
15-PGDH, IC50: 1.5 nM 15-PGDH, Ki: 0.1 nM |
99%+ | |||||||||||||||||
| Mycophenolic acid | ✔ | 99+% | |||||||||||||||||
| Fomepizole | ✔ | 98% | |||||||||||||||||
| Leflunomide | ✔ | 98% | |||||||||||||||||
| 3-Nitropropanoic acid | ✔ | 99%+ | |||||||||||||||||
| Isovaleramide | ✔ | 99% | |||||||||||||||||
| Mycophenolate Mofetil |
+++
Inosine monophosphate dehydrogenase II, IC50: 27 nM Inosine monophosphate dehydrogenase I, IC50: 39 nM |
98% | |||||||||||||||||
| MK-8245 |
++++
SCD1 (rat), IC50: 3 nM SCD1 (mouse), IC50: 1 nM |
99%+ | |||||||||||||||||
| Vidofludimus |
++
Human DHODH, IC50: 134 nM |
99%+ | |||||||||||||||||
| Emodin | ✔ | 98% | |||||||||||||||||
| Ivosidenib | ✔ | 98% | |||||||||||||||||
| NCT-501 |
++
ALDH1A1, IC50: 40 nM |
98% | |||||||||||||||||
| Gossypol | ✔ | 99%+ | |||||||||||||||||
| Devimistat | ✔ | 98% | |||||||||||||||||
| Disulfiram | ✔ | 98%+ | |||||||||||||||||
| Enasidenib |
++++
IDH2, IC50: 12 nM |
98% | |||||||||||||||||
| PluriSIn 1 | ✔ | 99%+ | |||||||||||||||||
| ML390 |
+
DHODH, IC50: 0.56 μM |
99%+ | |||||||||||||||||
| Teriflunomide | ✔ | 99%+ | |||||||||||||||||
| Daidzin |
+++
ALDH-Ⅰ, Ki: 20 nM |
98+% | |||||||||||||||||
| 18β-Glycyrrhetinic acid | ✔ | 99% | |||||||||||||||||
| RRx-001 | ✔ | 95% | |||||||||||||||||
| NCT-503 |
+
PHGDH, IC50: 2.5 μM |
99%+ | |||||||||||||||||
| Vorasidenib | ✔ | 99%+ | |||||||||||||||||
| Ammonium Glycyrrhizinate(x:1) | ✔ | 98+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Trilostane is a recognized treatment for canine pituitary-dependent hyperadrenocorticism (PDH); The median survival time for animals treated with trilostane was 353 days (95% confidence interval [CI] 95-528 days)[3]. During trilostane therapy, urinary catecholamines and their metabolites did not decrease significantly. However, dogs with low post-ACTH cortisol concentrations during trilostane therapy had less increased epinephrine, norepinephrine and normetanephrine, creatinine ratios compared to healthy dogs[4]. In a substantial number of dogs treated with trilostane, the two prepill cortisol concentrations differed. Part of this difference might be ascribable to stressful events during test performance[5]. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01615211 | Medical Abortion, Complete or ... 展开 >>Unspecified, Without Complication 收起 << | Phase 2 | Terminated(No access to study ... 展开 >>drug Trilostan. Company closed down) 收起 << | - | Sweden ... 展开 >> Karolinska University Hospital Stockholm, Sweden, 17177 收起 << |
| NCT00181597 | Prostate Cancer ... 展开 >> Prostate Adenocarcinoma 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.04mL 0.61mL 0.30mL |
15.18mL 3.04mL 1.52mL |
30.36mL 6.07mL 3.04mL |
|
| CAS号 | 13647-35-3 |
| 分子式 | C20H27NO3 |
| 分子量 | 329.43 |
| SMILES Code | C[C@@]12[C@@H](O)CC[C@@]1([H])[C@]3([H])CC[C@]45[C@](O5)([H])C(O)=C(C#N)C[C@]4(C)[C@@]3([H])CC2 |
| MDL No. | MFCD00199295 |
| 别名 | 曲洛斯坦 ;Win 24540; Desopan; Modrenal.; Modrastane. Desopan; D-01180; DB01108; Vetoryl; Modrefen |
| 运输 | 蓝冰 |
| InChI Key | KVJXBPDAXMEYOA-CXANFOAXSA-N |
| Pubchem ID | 656583 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 55 mg/mL(166.95 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1